[Cannabis] Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week

Browse By

Cannabis Countdown: Top 10 Marijuana Stock News Stories of the Week

Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 marijuana stock news stories for the week of January 6th – 12th, 2020.

Without further ado, let’s get started.

10. 3 Pot Stocks With New Analyst Ratings and Price Targets, Potential Upside of 51%, 91% and 245%

All 3 Marijuana Stocks Still Have Great Upside From Current Levels

After Aurora Cannabis was downgraded and received a new target price, these 3 North American Cannabis Stocks also had its ratings and price targets adjusted this week. Read what each analyst had to say as well as their 2020 and 2021 earnings forecast.

READ FULL NEW RATINGS ARTICLE

9. Is This the Best Cannabis ETF of Them All? Let’s Take a Look at the Fund’s Holdings

MJJ ETF Has Likely Bottomed and Could Be an Excellent Value Buy at These Levels

Purpose Marijuana Opportunities Fund (NEO: MJJ) is a Cannabis ETF that provides investors with diversified exposure to North American and global Pot Stocks. The fund has a world-class portfolio manager and can also invest in private companies and initial public offerings (IPO).

READ FULL CANNABIS ETF ARTICLE

8. Trulieve Slaps Short-Seller Grizzly Research With Libel Lawsuit

Grizzly Research and Trulieve Are Headed for the Florida Courts

Trulieve Cannabis (CSE: TRUL) (OTCQX: TCNNF) is hitting back against the ‘short and distort’ stock manipulator Grizzly Research after it was reported that the company officially filed a lawsuit against the short-seller in the state of 

Full story available on Benzinga.com

Source Benzinga

Disclaimer: All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. The author is not paid to share this information. Cannabis Investment Group is not paid to share this information and has no business relationship other than shareholder with any company whose stock is mentioned in this article.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.